Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2/MyD88 and SNAP23

BACKGROUND: Botulinum toxin type A (BTX-A) was considered to be a new potential drug for neuropathic pain (NP) treatment. RESULTS: In vivo, BTX-A attenuated chronic compression injury (CCI)-induced pain in rats, and reduced production of pro-inflammatory factors. The inhibition of BTX-A to expressio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Biosci
Main Authors: Wang, Xuan, Tian, Sheng, Wang, Hansen, Liu, Pan, Zheng, Heqing, Wu, Lanxiang, Liu, Qian, Wu, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724852/
https://ncbi.nlm.nih.gov/pubmed/33298171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-020-00501-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados